Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
May 12, 2023 at 01:36 am IST
Anebulo Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported net loss was USD 2.8 million compared to USD 1.88 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.08 a year ago.
For the nine months, net loss was USD 9.24 million compared to USD 4.5 million a year ago. Basic loss per share from continuing operations was USD 0.37 compared to USD 0.19 a year ago.